The lung biopsy systems market is projected to grow from USD 3.0 billion in 2025 to USD 7.4 billion by 2035, at a CAGR of 9.4%. Core Needle Biopsy Devices will dominate with a 46.8% market share, while needle biopsy will lead the procedure type segment with a 57.3% share.